All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Universal Vision Biotechnology Co., Ltd revenue reports

Universal Vision Biotechnology Co., Ltd financial reports, Universal Vision Biotechnology Co., Ltd annual revenue in 2024. When does Universal Vision Biotechnology Co., Ltd report revenue?
Add to widgets
Added to widgets

Universal Vision Biotechnology Co., Ltd total revenue, net income and dynamics of changes in Taiwan new dollar today

Universal Vision Biotechnology Co., Ltd net revenue for today is 610 275 000 $. The dynamics of Universal Vision Biotechnology Co., Ltd net revenue grew by 35 929 000 $ compared to the previous report. Net income of Universal Vision Biotechnology Co., Ltd today amounted to 149 435 000 $. The financial report on the chart of Universal Vision Biotechnology Co., Ltd allows you to clearly see the dynamics of fixed assets. All information on Universal Vision Biotechnology Co., Ltd total revenue on this chart is created in the form of yellow bars. A graph of the value of all Universal Vision Biotechnology Co., Ltd assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 19 530 478 866.53 $ +96.21 % ↑ 4 782 331 095.69 $ +219.42 % ↑
31/12/2020 18 380 652 025.85 $ +86.46 % ↑ 4 060 893 079.89 $ +135.73 % ↑
30/09/2020 19 201 874 619.26 $ +65.46 % ↑ 4 863 586 080.47 $ +190.13 % ↑
30/06/2020 15 489 043 459.24 $ +34.92 % ↑ 3 679 964 334.74 $ +56.88 % ↑
30/09/2019 11 605 125 592.38 $ - 1 676 368 102.88 $ -
30/06/2019 11 479 834 822.21 $ - 2 345 673 637.30 $ -
31/03/2019 9 953 943 654.53 $ - 1 497 184 700.03 $ -
31/12/2018 9 857 775 387.78 $ - 1 722 708 086.33 $ -
Show:
to

Universal Vision Biotechnology Co., Ltd financial report charts

Dates of Universal Vision Biotechnology Co., Ltd finance reports: 31/12/2018, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Universal Vision Biotechnology Co., Ltd for today is 31/03/2021. Gross profit Universal Vision Biotechnology Co., Ltd is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Universal Vision Biotechnology Co., Ltd is 389 225 000 $

Universal Vision Biotechnology Co., Ltd quarterly report dates

Cost of revenue Universal Vision Biotechnology Co., Ltd is the total cost of producing and distributing of products and services of a company. Cost of revenue Universal Vision Biotechnology Co., Ltd is 221 050 000 $ Total revenue Universal Vision Biotechnology Co., Ltd refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Universal Vision Biotechnology Co., Ltd is 610 275 000 $ Operating income Universal Vision Biotechnology Co., Ltd is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Universal Vision Biotechnology Co., Ltd is 192 963 000 $

Net income Universal Vision Biotechnology Co., Ltd is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Universal Vision Biotechnology Co., Ltd is 149 435 000 $ Current assets Universal Vision Biotechnology Co., Ltd is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Universal Vision Biotechnology Co., Ltd is 1 684 847 000 $ Total assets Universal Vision Biotechnology Co., Ltd refers to the total amount of assets owned by a person or entity. Total assets Universal Vision Biotechnology Co., Ltd is 3 260 132 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
12 456 270 757.98 $ 11 542 016 167.41 $ 12 200 344 758.23 $ 9 294 430 961.93 $ 6 522 000 640.05 $ 6 754 052 587.55 $ 5 423 410 203.72 $ 5 664 230 904.99 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
7 074 208 108.55 $ 6 838 635 858.44 $ 7 001 529 861.03 $ 6 194 612 497.32 $ 5 083 124 952.33 $ 4 725 782 234.67 $ 4 530 533 450.82 $ 4 193 544 482.79 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
19 530 478 866.53 $ 18 380 652 025.85 $ 19 201 874 619.26 $ 15 489 043 459.24 $ 11 605 125 592.38 $ 11 479 834 822.21 $ 9 953 943 654.53 $ 9 857 775 387.78 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
6 175 346 841.21 $ 5 184 957 706.02 $ 6 151 440 786.22 $ 4 517 956 369.67 $ 1 852 543 247.14 $ 2 327 432 069.23 $ 1 440 027 786.75 $ 1 623 371 547.23 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
4 782 331 095.69 $ 4 060 893 079.89 $ 4 863 586 080.47 $ 3 679 964 334.74 $ 1 676 368 102.88 $ 2 345 673 637.30 $ 1 497 184 700.03 $ 1 722 708 086.33 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - - - -
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
13 355 132 025.31 $ 13 195 694 319.83 $ 13 050 433 833.04 $ 10 971 087 089.57 $ 9 752 582 345.24 $ 9 152 402 752.99 $ 8 513 915 867.79 $ 8 234 403 840.55 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
53 919 739 014.10 $ 52 550 853 342.82 $ 52 856 799 642.38 $ 48 050 882 519.21 $ 39 229 900 255.58 $ 41 204 662 008.79 $ 42 658 322 967.46 $ 40 841 494 790.44 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
104 333 192 623.13 $ 101 421 326 315.14 $ 99 821 092 756.89 $ 93 466 946 545.84 $ 84 688 815 965.80 $ 86 206 130 396.21 $ 86 656 569 116.54 $ 67 104 264 373.83 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
22 630 009 306.38 $ 19 713 758 621.50 $ 16 676 921 570.86 $ 16 224 370 668.97 $ 15 234 557 583.29 $ 8 534 813 664.19 $ 13 197 262 454.63 $ 14 924 450 926.10 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 17 933 221 564.12 $ 19 687 228 340.92 $ 19 624 438 943.46 $ 14 884 831 520.36 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 31 941 529 737.34 $ 34 644 354 075.79 $ 33 904 738 497.43 $ 15 614 526 245.91 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 37.72 % 40.19 % 39.13 % 23.27 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
55 756 760 927 $ 61 250 033 136.15 $ 57 021 925 682.28 $ 52 444 252 179.24 $ 49 296 205 568.87 $ 48 064 739 710.39 $ 48 806 915 508.84 $ 47 260 126 544.75 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 5 130 233 001.81 $ 1 844 638 567.64 $ 3 031 396 582.97 $ 3 092 649 848.39 $

Last revenue report of Universal Vision Biotechnology Co., Ltd was 31/03/2021. According to last financial report total revenue in Universal Vision Biotechnology Co., Ltd was 19 530 478 866.53 Taiwan new dollar and changed by +96.21% since last year. Net income in Universal Vision Biotechnology Co., Ltd was 4 782 331 095.69 $ in last quartal, net income changes to +219.42%.

Current cash Universal Vision Biotechnology Co., Ltd - the sum of all of the cash a company has on the date of report. Current cash Universal Vision Biotechnology Co., Ltd is 707 127 000 $

Universal Vision Biotechnology Co., Ltd stocks data

Universal Vision Biotechnology Co., Ltd financials